RvD1 also diminishes several cytokines and chemokines that are increased in CF airways including IL-8, IL-1β, and IL-17 and has additive effects when co-administered with ciprofloxacin at sub-optimal doses (Codagnone et al., 2018). The gene discussed is CXCL8; the disease is cystic fibrosis.